Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Patrick D. Rowan"'
Publikováno v:
The Journal of Hip Surgery. :055-061
The purpose of this study was to analyze relevant initial-implantation biomechanical properties of five knotless suture anchors available for use in acetabular labral repair. Five knotless suture anchor constructs were tested: Arthrex PushLock 2.9, A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7b91f11e65ca6ef81ef8cb240f590d2
https://doi.org/10.1055/s-0041-1729870
https://doi.org/10.1055/s-0041-1729870
Autor:
Brent A, Ponce, Johnathan F, Williams, Shawna L, Watson, Jorge L, Perez, Parke W, Hudson, Jonathan H, Scott, Djuro, Petkovic, Christopher M, Jobe, Patrick D, Rowan, Wesley P, Phipatanakul
Publikováno v:
Journal of surgical orthopaedic advances. 28(2)
Fixation of proximal humerus fractures (PHFs) with intramedullary (IM) nails potentially is a newer, less invasive technique. The purpose of this study was to report on the early adoption results of IM nail use for PHF. Retrospective chart reviews we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7d9deec8538a72dd6e555e6dd1455482
https://pubmed.ncbi.nlm.nih.gov/31411957
https://pubmed.ncbi.nlm.nih.gov/31411957
Autor:
Deniz Peker, Juan Li, Kellie M. Regal, Timothy N. Trotter, Patrick D. Rowan, Amjad Javed, Larry J. Suva, Yang Yang, Qianying Pan
Publikováno v:
Oncotarget
Bone dissemination and bone disease occur in approximately 80% of patients with multiple myeloma (MM) and are a major cause of patient mortality. We previously demonstrated that MM cell-derived heparanase (HPSE) is a major driver of MM dissemination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3145e1551ed0dbe70fe19a77f1706fb1
https://doi.org/10.18632/oncotarget.7170
https://doi.org/10.18632/oncotarget.7170
Autor:
Timothy N. Trotter, Qianying Pan, Amjad Javed, Patrick D. Rowan, Juan Li, Fenghuang Zhan, Mei Li, Larry J. Suva, Yang Yang, Deniz Peker
The progression of multiple myeloma (MM) is governed by a network of molecular signals, the majority of which remain to be identified. Recent studies suggest that Runt-related transcription factor 2 (Runx2), a well-known bone-specific transcription f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55bb24ca63a392d8a79ec7279b98262b
https://europepmc.org/articles/PMC4458799/
https://europepmc.org/articles/PMC4458799/
Publikováno v:
Cancer Research. 75:4102-4102
Multiple myeloma (MM), a hematologic malignancy, preferentially grows in bone marrow and frequently metastasizes between bones. Our previous studies have demonstrated that heparanase (HPSE), an enzyme overexpressed in MM cells, promotes MM bone-metas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d14691398d7b21a0b490a6f56afbab79
https://doi.org/10.1158/1538-7445.am2015-4102
https://doi.org/10.1158/1538-7445.am2015-4102
Publikováno v:
Cancer Research. 75:2387-2387
Multiple myeloma (MM) is a hematologic malignancy of plasma cells that thrives in and metastasizes throughout the bone marrow microenvironment. This microenvironment is host to a variety of cell types, including osteoblasts, osteoclasts and stromal c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::838a7766ecbe4f49ff00edcbbd85abf8
https://doi.org/10.1158/1538-7445.am2015-2387
https://doi.org/10.1158/1538-7445.am2015-2387
Autor:
Timothy N. Trotter, Deniz Peker, Yang Yang, Patrick D. Rowan, Suva J. Larry, Mei Li, Pan Qianying, Amjad Javed
Publikováno v:
Blood. 124:724-724
Background. Multiple myeloma (MM), an incurable plasma-cell malignancy, preferentially grows in bone marrow and frequently metastasizes to new bone sites. The molecular network responsible for progression and bone-metastasis of MM remains largely unk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3353472364827ad15355607dc2d5a2e
https://doi.org/10.1182/blood.v124.21.724.724
https://doi.org/10.1182/blood.v124.21.724.724
Autor:
Yang Yang, Deniz Peker, Patrick D. Rowan, Mei Li, Qianying Pan, Timothy N. Trotter, Larry J. Suva, Racquel Innis-Shelton
Publikováno v:
Blood. 124:2025-2025
Background. Bone metastases occur in 80% of patients with multiple myeloma (MM) and are a major cause of patient mortality. We previously demonstrated that MM cell-derived heparanase (HPSE), an enzyme that cleaves heparan sulfate chains, is a master
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1767ae3d34940efb7eaa8c52290de30e
https://doi.org/10.1182/blood.v124.21.2025.2025
https://doi.org/10.1182/blood.v124.21.2025.2025